The Role of Retrotransposon Activity in Mammalian Pre-Implantation Development
逆转录转座子活性在哺乳动物植入前发育中的作用
基本信息
- 批准号:10594575
- 负责人:
- 金额:$ 24.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-18 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:5&apos Untranslated RegionsAccelerationAreaAutomobile DrivingBioinformaticsBiologicalBiologyBiosensorCRISPR/Cas technologyCell CycleCell Cycle ProgressionCell divisionCellsChimerismClustered Regularly Interspaced Short Palindromic RepeatsCodeCollaborationsCommunity DevelopmentsComplexConsumptionCrowdingDataData SetDefectDevelopmentDiseaseElectroporationElementsEmbryoEmbryo TransferEmbryonic DevelopmentEventExonsFamilyFertilityGene StructureGenesGeneticGenetic TranscriptionGenomeGlucoseGoalsHealthHomeostasisHumanHuman GenomeImmunofluorescence ImmunologicIn VitroIndividualInfertilityKnock-outKnockout MiceMetabolicMethodsMonitorMorulaMusMutationN-terminalNatureOpen Reading FramesPhasePhenotypePlacentaPoly APolyadenylationPositioning AttributePre-EclampsiaPre-implantation Embryo DevelopmentPregnancyPregnancy ComplicationsPregnancy lossProcessProtein BiosynthesisProtein IsoformsProteinsProteomeProteomicsPyruvateRNARNA SplicingRecurrenceRegulationReportingResearchRetrotransposonRoleSignal TransductionSiteSpecific qualifier valueStressSurveysTechniquesTechnologyTestingTimeTrainingTranscriptTranslationsUterusWestern BlottingWorkblastocystcareerconfocal imagingembryo cellgene regulatory networkgenetic manipulationgenome editingimplantationin vivoinsightmouse genomenatural Blastocyst Implantationnoveloverexpressionplacenta previapreimplantationpromoterribosome profilingsingle cell analysistranscriptometranscriptome sequencinguterine receptivity
项目摘要
Abstract
Nearly half of both human and mouse genomes originate from ancient retroviral integrations. While silenced in
nearly all cells, retrotransposon reactivation is a recognized phenomenon occurring in preimplantation embryos.
In a handful of reports, disruption of retrotransposon family expression resulted in embryonic lethality, suggesting
essential functions, but the cause of this is completely unknown. The majority of retrotransposons have been
inactivated through mutation. Still, many retain regulatory and structural features of intact elements, with rare
reports of retrotransposon influence of nearby genes. The highly repetitive nature of retrotransposons has made
studying their individual functions difficult, however re-analysis of single cell pre-implantation mouse embryos
revealed striking levels of dynamically expressed retrotransposon families. Most retrotransposons are only active
during defined windows of time, sometimes spanning a single cell division. Interestingly, a subset of these loci
are spliced with nearby protein coding genes, generating “chimeric transcripts” that form hundreds of novel
embryonic specific promoters, exons and polyadenylation sites. As a proof-of-principle, a highly efficient
electroporation based CRISPR embryo editing method developed in the lab was used to generate
retrotransposon deletions of two chimeric promoters. The deletion of the MT2B1 promoter driving Rpl41 results
in delayed global translation, causing stress induced arrest. The second, deletion of the MT2C_Mm promoter of
the cell cycle regulator Cdk2ap1, results in small litters, physical abnormalities, embryo spacing, crowding and
implantation into unsuitable uterine sites, reminiscent of the human pregnancy complications placenta previa,
accreta and potentially pre-eclampsia. Thus, the applicant hypothesizes that retrotransposon reactivation and
transcript chimerism in preimplantation is essential for early embryonic development and implantation. During
the K99 phase, the applicant will train in three cutting edge technologies: automated live cell spinning disk
confocal imaging, single cell/embryo Western Blot with Dr. Amy Herr and ultra-low input Ribosome Profiling of
Embryos with Dr. Nicholas Ingolia. These collaborations and additional coursework will help the applicant master
the techniques needed for long term academic and career goals. To this end, Aim1 will serve to understand the
cellular cause of the implantation defects of the M2TC_Mm:CKD2ap1 deletion, offering insight into novel
explanations for related human pregnancy issues. Aim2 will work to elucidate the role of M2TB1:Rpl41 in global
translation as well as to gain insight into the oxidative and metabolic needs of the developing embryo. Aims 1
and 2 will be completed during the K99 phase. During the R00 phase, Aim 3 will work to determine the extent of
retrotransposon influence on the preimplantation embryo. Together with Dr. Davide Risso, parallel analysis of
the embryo ribosome profiling and matched RNA-SEQ data will help to unravel and further test the complex re-
wiring of the preimplantation embryo by retrotransposon reactivation. As these reactivations are not unique to
the mouse, this work will establish a method to investigate this overlooked but important novel regulatory network
and offer additional explanations to human developmental phenotypes that thus far have no clear genetic cause.
抽象的
近一半的人类和小鼠基因组源自古老的逆转录病毒整合,但在沉默中。
几乎所有细胞中,逆转录转座子重新激活是发生在植入前胚胎中的一种公认现象。
在一些报告中,逆转录转座子家族表达的破坏导致胚胎致死,表明
基本功能,但其原因完全未知。大多数反转录转座子已被破坏。
尽管如此,许多仍保留完整元件的调控和结构特征,但很少有。
逆转录转座子对附近基因影响的报道 逆转录转座子的高度重复性使得
研究它们的个体功能很困难,但是对单细胞植入前小鼠胚胎进行重新分析
揭示了动态表达的反转录转座子家族的惊人水平,大多数反转录转座子只是活跃的。
在规定的时间窗口内,有时跨越单个细胞分裂。
与附近的蛋白质编码基因拼接,产生“嵌合转录本”,形成数百个新的
胚胎特异性启动子、外显子和聚腺苷酸化位点作为原理证明,是一种高效的方法。
实验室开发的基于电穿孔的CRISPR胚胎编辑方法被用来产生
两个嵌合启动子的逆转录转座子缺失导致驱动 Rpl41 的 MT2B1 启动子缺失。
延迟全局翻译,导致应激诱导停滞。第二,MT2C_Mm 启动子的缺失。
细胞周期调节因子 Cdk2ap1,导致窝产数少、身体异常、胚胎间隔、拥挤和
植入不合适的子宫部位,让人想起人类妊娠并发症前置胎盘,
因此,申请人热衷于逆转录转座子的重新激活和潜在的先兆子痫。
植入前的转录嵌合对于早期胚胎发育和植入至关重要。
K99阶段,申请人将接受三项尖端技术的培训:自动化活细胞旋转盘
共聚焦成像、Amy Herr 博士的单细胞/胚胎蛋白质印迹以及超低输入核糖体分析
与 Nicholas Ingolia 博士的胚胎这些合作和额外的课程将帮助申请人掌握。
长期学术和职业目标所需的技术 为此,Aim1 将有助于理解
M2TC_Mm:CKD2ap1 缺失植入缺陷的细胞原因,提供了新的见解
Aim2 将致力于阐明 M2TB1:Rpl41 在全球范围内的作用。
翻译以及深入了解发育中胚胎的氧化和代谢需求 目标 1。
目标 2 将在 K99 阶段完成 在 R00 阶段,目标 3 将确定目标的范围。
与 Davide Risso 博士一起平行分析逆转录转座子对植入前胚胎的影响。
胚胎核糖体分析和匹配的RNA-SEQ数据将有助于解开并进一步测试复杂的重新
通过逆转录转座子重新激活来连接植入前胚胎,因为这些重新激活并非是所独有的。
小鼠,这项工作将建立一种方法来研究这个被忽视但重要的新型调控网络
并对迄今为止尚无明确遗传原因的人类发育表型提供更多解释。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrew Joseph Modzelewski其他文献
Andrew Joseph Modzelewski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrew Joseph Modzelewski', 18)}}的其他基金
The Role of Retrotransposon Activity in Mammalian Pre-Implantation Development
逆转录转座子活性在哺乳动物植入前发育中的作用
- 批准号:
10550023 - 财政年份:2022
- 资助金额:
$ 24.89万 - 项目类别:
The Role of Retrotransposon Activity in Mammalian Pre-Implantation Development
逆转录转座子活性在哺乳动物植入前发育中的作用
- 批准号:
10267659 - 财政年份:2018
- 资助金额:
$ 24.89万 - 项目类别:
Investigating the role of Retrotransposon muERV-L reactivation in Tumorigenesis
研究逆转录转座子 muERV-L 重新激活在肿瘤发生中的作用
- 批准号:
8832362 - 财政年份:2015
- 资助金额:
$ 24.89万 - 项目类别:
相似海外基金
Optimization of CRISPR genome editor and its delivery strategy for C9orf72 frontotemporal dementia
C9orf72额颞叶痴呆的CRISPR基因组编辑器优化及其递送策略
- 批准号:
10746565 - 财政年份:2023
- 资助金额:
$ 24.89万 - 项目类别:
The role of translation initiation factor eIF5B in lung cancer pathogenesis
翻译起始因子eIF5B在肺癌发病机制中的作用
- 批准号:
10734752 - 财政年份:2023
- 资助金额:
$ 24.89万 - 项目类别:
Fluorescent IRE sensor for synucleinopathy drug discovery
用于突触核蛋白病药物发现的荧光 IRE 传感器
- 批准号:
10708197 - 财政年份:2022
- 资助金额:
$ 24.89万 - 项目类别:
Epigenetic Mechanisms Contributing to the Pathogenesis of ALS/FTD with GGGGCC Repeat Expansion Mutation at the C9orf72 Locus
C9orf72 基因座 GGGGCC 重复扩增突变导致 ALS/FTD 发病机制的表观遗传机制
- 批准号:
10792462 - 财政年份:2022
- 资助金额:
$ 24.89万 - 项目类别:
Molecular mechanisms of eukaryotic translational control
真核翻译控制的分子机制
- 批准号:
10614648 - 财政年份:2022
- 资助金额:
$ 24.89万 - 项目类别: